0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Case Reports and Small Case Series |

Pars Plana Tube Insertion of Aqueous Shunt With Vitrectomy in Malignant Glaucoma FREE

Augusto Azuara-Blanco, MD, PhD; L. Jay Katz, MD; Sai B. Gandham, MD; George L. Spaeth, MD
Arch Ophthalmol. 1998;116(6):808-810. doi:.
Text Size: A A A
Published online

Medical treatment, laser surgery, and vitreous surgery have been useful options to treat aqueous misdirection (malignant glaucoma). Two patients with pseudophakic malignant glaucoma unresponsive to medical treatment underwent pars plana vitrectomy and tube shunt implantation through the pars plana. The outcome was favorable in both patients. The implantation of the tube shunt through pars plana can help prevent recurrence of this condition by avoiding reaccumulation of fluid in the posterior segment of the eye, and can help in long-term control of intraocular pressure (IOP) in these glaucomatous patients.

"Aqueous misdirection" or "malignant glaucoma" is characterized by flattening of the anterior chamber without pupillary block or choroidal effusion or suprachoroidal hemorrhage, usually with an accompanying rise in IOP. To explain the pathogenesis of this condition, Shaffer1 proposed that aqueous is diverted posteriorly toward the vitreous cavity. Medical treatment,2 laser surgery,3,4 and vitreous surgery59 have all been useful options to treat this condition.

We report a new method of surgical treatment for malignant glaucoma, consisting of vitrectomy and tube shunt implantation through the pars plana.

Case 1

An 86-year-old white woman was first seen in our service in September 1996 because of a shallow anterior chamber associated with episodes of high IOP in the right eye. The patient had had 2 Nd:YAG laser peripheral iridotomies after cataract extraction, which had been performed 6 years before coming to us. The IOP was quite labile despite medicinal treatment. The left eye was amblyopic and had developed "pupillary block" after cataract extraction; a peripheral iridectomy had not helped control the IOP and the vision in the left eye had been lost.

On presentation, the visual acuity was 20/100 OD and no light perception in the left eye. The IOP was 42 mm Hg in the right eye and 12 mm Hg in the left. Treatment for the right eye was 2% dorzolamide hydrochloride thrice daily, 0.5% timolol maleate twice daily, 0.005% latanoprost at bedtime, and 50 mg of methazolamide orally twice daily, and treatment for the left eye was 1% prednisolone acetate twice daily and 1% atropine sulfate twice daily. The right eye had a shallow anterior chamber, 0.9 mm in depth (Figure 1). There were 2 patent peripheral iridotomies. The left eye had a deep anterior chamber. The anterior chamber angle was closed by peripheral anterior synechiae, 360° in both eyes. The optic disc of the right eye showed advanced glaucomatous cupping; the cupping was total in the left eye. Visual field examination of the right eye with a computerized perimeter (threshold strategy) revealed a severe constriction of the visual field, and with a marked depression of the retinal sensitivity in the arcuate areas. Ultrasound biomicroscopy ruled out ciliary or choroidal effusion or suprachoroidal hemorrhage.

Place holder to copy figure label and caption
Figure 1.

Slitlamp photograph of the right eye in case 1. The anterior chamber is very shallow. Two (patent) peripheral iridotomies are barely seen at the 10- and 1-o'clock positions.

Graphic Jump Location

Additional medical treatment was prescribed: 1% tropicamide 4 times daily, 1% atropine sulfate 4 times daily, and 2.5% phenylephrine hydrochloride 4 times daily. Topical and systemic aqueous suppressants were continued, but 24 hours later the anterior chamber depth and IOP were unchanged in the right eye. Neodymium:YAG laser capsulotomy was considered, but believed unlikely to be of adequate immediate benefit. The severity of the glaucomatous damage and high IOP, which prompted an urgent and effective intervention, and the presence of peripheral anterior synechiae in the anterior chamber angle, which would probably impede a satisfactory long-term control of IOP, were the factors considered in the surgical planning. The patient underwent a standard 3-port pars plana vitrectomy, removing the anterior vitreous and adhesions around the peripheral iridectomies; a Baerveldt (350 mm2) tube shunt was implanted through the pars plana. This surgical technique has been described elsewhere.59 During the procedure, the anterior chamber deepened. The postoperative outcome was uncomplicated (Figure 2). Six months later, the visual acuity in the right eye was 20/80, IOP was 13 mm Hg with no medical treatment, the anterior chamber was deep, and there was no apparent complication.

Place holder to copy figure label and caption
Figure 2.

Slitlamp photograph of the same eye as in Figure 1 four weeks after surgery. The anterior chamber is deep. The temporal iridotomy has been enlarged.

Graphic Jump Location
Case 2

A 72-year-old white woman developed pain and blurred vision in the left eye. She had previously had Nd:YAG laser peripheral iridotomies in both eyes and 2 weeks before coming to us had undergone an uncomplicated phacoemulsification with posterior chamber intraocular lens implantation in the left eye. The visual acuity was 20/30 OD and counting fingers at 120 cm OS. The IOP was 15 mm Hg in the right eye and 48 mm Hg in the left. Treatment in the left eye consisted of 0.5% timolol maleate twice daily, 0.2% brimonidine tartrate thrice daily, 2% dorzolamide thrice daily, and 1% cyclopentolate hydrochloride twice daily. The right eye had a clear cornea, a moderately shallow anterior chamber, 2 patent iridotomies, and a moderately dense nuclear cataract. The cornea of the left eye had diffuse corneal edema and a very shallow central anterior chamber but without lens-corneal touch. Two patent iridotomies were present at the 12- and 2-o'clock positions. Gonioscopy with indentation revealed a closed anterior chamber angle. The retina was attached, without peripheral choroidal or retinal abnormalities. The optic disc had moderate glaucomatous damage. Visual field examination was not performed.

The patient was treated with intravenous mannitol solution and oral acetazolamide; the current topical treatment was supplemented with 2.5% phenylephrine hydrochloride 4 times daily. The following day the corneal edema in the left eye persisted, the anterior chamber depth was unchanged, and the IOP was 29 mm Hg. Neodymium:YAG laser was not performed because of the lack of corneal clarity. The patient underwent a pars plana vitrectomy and a Baerveldt (250 mm2) tube shunt implantation. The tube tip was placed in the posterior segment through the pars plana. The anterior chamber deepened during the procedure. The postoperative period was uneventful. Four months after surgery in the left eye, the best-corrected visual acuity was 20/25, the anterior chamber was deep, and IOP was 10 mm Hg.

Malignant glaucoma or aqueous misdirection is initially managed with mydriatic-cycloplegic drops, aqueous suppressants, and hyperosmotics.2 If medicinal therapy is unsuccessful, laser or surgical intervention is usually advised. Pars plana vitrectomy can be effective when other therapies fail, especially in pseudophakic and aphakic eyes.59 However, after resolving the attack of aqueous misdirection itself, the IOP can remain elevated or even increase due to other factors. Chronic angle closure glaucoma and/or failure of previous filtering surgery can occur in cases of malignant glaucoma after successful pars plana vitrectomy: all 5 cases reported by Momoeda et al5 required medicinal treatment, and 2 of 5 patients required further filtration surgery after successful reversal of malignant glaucoma by pars plana vitrectomy, associated with intracapsular cataract extraction. The filtering bleb failed in 1 of the 2 patients with pseudophakic malignant glaucoma, which was treated by vitrectomy, as described by Lynch et al.6 Byrnes et al7 observed failure of the bleb after vitrectomy for ciliary block glaucoma in 4 of 19 cases. Harbour et al8 recently described 21 patients with malignant glaucoma treated with vitrectomy; 4 had postoperative visual loss due to progressive glaucoma.8

Although pars plana tube insertion with vitrectomy has been used to treat neovascular glaucomas and glaucomas associated with pseudophakia and aphakia,1012 to our knowledge, the use of this technique to treat malignant glaucomas has not been reported previously.

In the 2 patients described herein, prompt surgical intervention was indicated owing to the lack of response to the initial medicinal treatment, the level of IOP, the advanced glaucomatous damage (case 1), and the presence of corneal edema (case 2). In patients without advanced glaucomatous damage, medical treatment should be tried for 2 to 4 days before surgical intervention, and, when possible, Nd:YAG laser treatment can be tried. The satisfactory postoperative outcome probably reflects the efficacy of pars plana vitrectomy in treating the aqueous misdirection and tube shunt implantation in controlling the IOP. It is also likely that the tube inserted through the pars plana will prevent recurrence of this condition. However, it is not known whether more prolonged medical therapy or pars plana vitrectomy without tube shunt implantation would have been sufficient.

We suggest that pars plana tube insertion with vitrectomy can be a useful technique to treat patients with malignant glaucoma and a closed anterior chamber angle. This technique can effectively relieve the aqueous misdirection. The implantation of the tube shunt through pars plana can help prevent recurrence of this condition, and can help in long-term control of IOP in glaucomatous patients. This technique appears to be especially appropriate for patients with moderate or severe glaucomatous damage.

Dr Azuara-Blanco is now with Queen's Medical Centre, University of Nottingham, Nottingham, England.

Corresponding author: L. Jay Katz, MD, Wills Eye Hospital, 900 Walnut St, Philadelphia, PA 19107 (e-mail: ljk22222@aol.com).

Shaffer  R Role of vitreous detachment in aphakic and malignant glaucoma. Trans Am Acad Ophthalmol Otolaryngol. 1954;58217- 231
Chandler  PASimmons  RJGrant  EM Malignant glaucoma: medical and surgical treatment. Am J Ophthalmol. 1968;66495- 502
Herschler  J Laser shrinkage of the ciliary processes: a treatment for malignant (ciliary block) glaucoma. Ophthalmology. 1980;871155- 1159
Link to Article
Epstein  DLSteinert  RFPuliafito  CA Neodymium:YAG laser therapy to the anterior hyaloid in aphakic malignant (ciliary block) glaucoma. Ophthalmology. 1980;871155- 1159
Link to Article
Momoeda  SHayashi  HOshima  K Anterior pars plana vitrectomy for phakic malignant glaucoma. Jpn J Ophthalmol. 1983;2773- 79
Lynch  MGBrown  RHMichels  RGPollack  IPStark  WJ Surgical vitrectomy for pseudophakic malignant glaucoma. Am J Ophthalmol. 1986;102149- 153
Link to Article
Byrnes  GALeen  MMWong  TPBenson  WE Vitrectomy for ciliary block (malignant) glaucoma. Ophthalmology. 1995;1021308- 1311
Link to Article
Harbour  JWRubsamen  PEPalmberg  P Pars plana vitrectomy in the management of phakic and pseudophakic malignant glaucoma. Arch Ophthalmol. 1996;1141073- 1078
Link to Article
Weiss  HShin  DHKollarits  CR Vitrectomy for malignant (ciliary block) glaucomas. Int Ophthalmol Clin. 1981;21113- 119
Link to Article
Lloyd  MAHeuer  DKBaerveldt  G  et al.  Combined Molteno implantation and pars plana vitrectomy for neovascular glaucoma. Ophthalmology. 1991;981401- 1405
Link to Article
Gandham  SBCosta  VPKatz  LJ  et al.  Aqueous tube-shunt implantation and pars plana vitrectomy in eyes with refractory glaucoma. Am J Ophthalmol. 1993;116189- 195
Varma  RHeuer  DKLundy  DCBaerveldt  GLee  PPMinckler  DS Pars plana Baerveldt tube insertion with vitrectomy in glaucomas associated with pseudophakia and aphakia. Am J Ophthalmol. 1995;119401- 407

Figures

Place holder to copy figure label and caption
Figure 1.

Slitlamp photograph of the right eye in case 1. The anterior chamber is very shallow. Two (patent) peripheral iridotomies are barely seen at the 10- and 1-o'clock positions.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Slitlamp photograph of the same eye as in Figure 1 four weeks after surgery. The anterior chamber is deep. The temporal iridotomy has been enlarged.

Graphic Jump Location

Tables

References

Shaffer  R Role of vitreous detachment in aphakic and malignant glaucoma. Trans Am Acad Ophthalmol Otolaryngol. 1954;58217- 231
Chandler  PASimmons  RJGrant  EM Malignant glaucoma: medical and surgical treatment. Am J Ophthalmol. 1968;66495- 502
Herschler  J Laser shrinkage of the ciliary processes: a treatment for malignant (ciliary block) glaucoma. Ophthalmology. 1980;871155- 1159
Link to Article
Epstein  DLSteinert  RFPuliafito  CA Neodymium:YAG laser therapy to the anterior hyaloid in aphakic malignant (ciliary block) glaucoma. Ophthalmology. 1980;871155- 1159
Link to Article
Momoeda  SHayashi  HOshima  K Anterior pars plana vitrectomy for phakic malignant glaucoma. Jpn J Ophthalmol. 1983;2773- 79
Lynch  MGBrown  RHMichels  RGPollack  IPStark  WJ Surgical vitrectomy for pseudophakic malignant glaucoma. Am J Ophthalmol. 1986;102149- 153
Link to Article
Byrnes  GALeen  MMWong  TPBenson  WE Vitrectomy for ciliary block (malignant) glaucoma. Ophthalmology. 1995;1021308- 1311
Link to Article
Harbour  JWRubsamen  PEPalmberg  P Pars plana vitrectomy in the management of phakic and pseudophakic malignant glaucoma. Arch Ophthalmol. 1996;1141073- 1078
Link to Article
Weiss  HShin  DHKollarits  CR Vitrectomy for malignant (ciliary block) glaucomas. Int Ophthalmol Clin. 1981;21113- 119
Link to Article
Lloyd  MAHeuer  DKBaerveldt  G  et al.  Combined Molteno implantation and pars plana vitrectomy for neovascular glaucoma. Ophthalmology. 1991;981401- 1405
Link to Article
Gandham  SBCosta  VPKatz  LJ  et al.  Aqueous tube-shunt implantation and pars plana vitrectomy in eyes with refractory glaucoma. Am J Ophthalmol. 1993;116189- 195
Varma  RHeuer  DKLundy  DCBaerveldt  GLee  PPMinckler  DS Pars plana Baerveldt tube insertion with vitrectomy in glaucomas associated with pseudophakia and aphakia. Am J Ophthalmol. 1995;119401- 407

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic